Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
Michael J. Haller, S. Alice Long, J. Lori Blanchfield, Desmond Schatz et autres
us (code pays fourni par la source)
135 citations
Diabetes